• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中用于延长药物释放的“智能”递药系统的最新进展。

Recent advances in "smart" delivery systems for extended drug release in cancer therapy.

机构信息

Department of Biomedical and Molecular Sciences, Queen's University,

Postgraduate Medical Education, Graduate Diploma and Professional Master in Medical Sciences, School of Medicine, Queen's University.

出版信息

Int J Nanomedicine. 2018 Aug 20;13:4727-4745. doi: 10.2147/IJN.S168053. eCollection 2018.

DOI:10.2147/IJN.S168053
PMID:30154657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6108334/
Abstract

Advances in nanomedicine have become indispensable for targeted drug delivery, early detection, and increasingly personalized approaches to cancer treatment. Nanoparticle-based drug-delivery systems have overcome some of the limitations associated with traditional cancer-therapy administration, such as reduced drug solubility, chemoresistance, systemic toxicity, narrow therapeutic indices, and poor oral bioavailability. Advances in the field of nanomedicine include "smart" drug delivery, or multiple levels of targeting, and extended-release drug-delivery systems that provide additional methods of overcoming these limitations. More recently, the idea of combining smart drug delivery with extended-release has emerged in hopes of developing highly efficient nanoparticles with improved delivery, bioavailability, and safety profiles. Although functionalized and extended-release drug-delivery systems have been studied extensively, there remain gaps in the literature concerning their application in cancer treatment. We aim to provide an overview of smart and extended-release drug-delivery systems for the delivery of cancer therapies, as well as to introduce innovative advancements in nanoparticle design incorporating these principles. With the growing need for increasingly personalized medicine in cancer treatment, smart extended-release nanoparticles have the potential to enhance chemotherapy delivery, patient adherence, and treatment outcomes in cancer patients.

摘要

纳米医学的进步对于靶向药物输送、早期检测以及日益个性化的癌症治疗方法至关重要。基于纳米粒子的药物输送系统克服了传统癌症治疗管理中存在的一些限制,例如降低药物溶解度、化疗耐药性、全身毒性、狭窄的治疗指数和较差的口服生物利用度。纳米医学领域的进展包括“智能”药物输送或多层次靶向以及延长释放药物输送系统,这些系统提供了克服这些限制的额外方法。最近,将智能药物输送与延长释放相结合的想法已经出现,希望开发出具有改善的输送、生物利用度和安全性的高效纳米粒子。尽管已经对功能化和延长释放药物输送系统进行了广泛的研究,但在其在癌症治疗中的应用方面,文献中仍存在空白。我们旨在提供智能和延长释放药物输送系统在癌症治疗中的应用概述,并介绍结合这些原理的纳米粒子设计的创新进展。随着癌症治疗中对日益个性化医学的需求不断增长,智能延长释放纳米粒子有可能增强化疗药物的输送、患者的依从性以及癌症患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/4b3e26b459b1/ijn-13-4727Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/945622f94430/ijn-13-4727Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/054101d1fa3f/ijn-13-4727Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/7070e8d36c11/ijn-13-4727Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/4fda191e8001/ijn-13-4727Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/4b3e26b459b1/ijn-13-4727Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/945622f94430/ijn-13-4727Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/054101d1fa3f/ijn-13-4727Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/7070e8d36c11/ijn-13-4727Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/4fda191e8001/ijn-13-4727Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a79/6108334/4b3e26b459b1/ijn-13-4727Fig5.jpg

相似文献

1
Recent advances in "smart" delivery systems for extended drug release in cancer therapy.癌症治疗中用于延长药物释放的“智能”递药系统的最新进展。
Int J Nanomedicine. 2018 Aug 20;13:4727-4745. doi: 10.2147/IJN.S168053. eCollection 2018.
2
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.癌症治疗的靶向纳米医学:迈向克服耐药性的精准医学。
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
3
Smart Drug-Delivery Systems for Cancer Nanotherapy.智能药物输送系统用于癌症纳米治疗。
Curr Drug Targets. 2018 Feb 19;19(4):339-359. doi: 10.2174/1389450117666160527142544.
4
Nanoparticle approaches to combating drug resistance.对抗耐药性的纳米颗粒方法。
Future Med Chem. 2015 Aug;7(12):1503-10. doi: 10.4155/fmc.15.82. Epub 2015 Aug 27.
5
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.用于癌症治疗的可生物降解聚合物纳米颗粒递送系统。
Nanomedicine (Lond). 2007 Oct;2(5):669-80. doi: 10.2217/17435889.2.5.669.
6
Smart Drug Delivery Systems in Cancer Therapy.智能药物输送系统在癌症治疗中的应用。
Curr Drug Targets. 2018 Feb 8;19(3):202-212. doi: 10.2174/1389450117666160401124624.
7
Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.新兴纳米药物在癌症早期检测和治疗改善方面的应用:当前的视角和未来的前景。
Pharmacol Ther. 2010 Nov;128(2):324-35. doi: 10.1016/j.pharmthera.2010.07.007. Epub 2010 Aug 10.
8
Nanomedicine for Treatment of Lung Cancer.用于治疗肺癌的纳米医学
Adv Exp Med Biol. 2016;890:137-47. doi: 10.1007/978-3-319-24932-2_8.
9
Therapeutic efficacy of nanomedicines for prostate cancer: An update.纳米药物对前列腺癌的治疗效果:最新进展
Investig Clin Urol. 2016 Jan;57(1):21-9. doi: 10.4111/icu.2016.57.1.21. Epub 2016 Jan 11.
10
Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.影响癌症纳米药物递送效率的因素。
AAPS PharmSciTech. 2020 May 14;21(4):132. doi: 10.1208/s12249-020-01691-3.

引用本文的文献

1
Nanocarrier drug delivery systems for gynecological cancer therapeutics.用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
2
Preparation and evaluation of lipid-based sustained release pellets of chlorpheniramine maleate by the wet extrusion-spheronization method.采用湿法制粒-滚圆法制备马来酸氯苯那敏脂质型缓释微丸并进行评价。
Bioimpacts. 2024 Jul 8;15:30098. doi: 10.34172/bi.30098. eCollection 2025.
3
Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review.

本文引用的文献

1
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML.重新定义急性髓系白血病:脂质体阿糖胞苷和柔红霉素(CPX-351)作为继发性急性髓系白血病的新兴疗法。
Onco Targets Ther. 2018 Jun 12;11:3425-3434. doi: 10.2147/OTT.S141212. eCollection 2018.
2
Performance status dynamics during treatment with -paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer.与单用吉西他滨相比,在转移性胰腺癌患者中使用紫杉醇加吉西他滨治疗期间的体能状态变化情况
Cancer Manag Res. 2018 May 31;10:1389-1396. doi: 10.2147/CMAR.S163475. eCollection 2018.
3
用于抗癌应用的磁性纳米颗粒与药物递送系统:综述
Nanomaterials (Basel). 2025 Feb 13;15(4):285. doi: 10.3390/nano15040285.
4
Photoactivated Multivariate Metal-Organic Frameworks for On-Demand Drug Release: The Role of Host-Guest Interactions.用于按需药物释放的光活化多元金属有机框架:主客体相互作用的作用
J Am Chem Soc. 2025 Mar 5;147(9):7423-7432. doi: 10.1021/jacs.4c15222. Epub 2025 Feb 24.
5
Colostrum-Derived Melatonin Plus PEG Microspheres Modulate the Oxidative Metabolism of Human Colostrum Phagocytes.初乳来源的褪黑素加聚乙二醇微球调节人初乳吞噬细胞的氧化代谢。
Metabolites. 2025 Jan 16;15(1):57. doi: 10.3390/metabo15010057.
6
Optimized Rutin-incorporating PEGylated Nanoliposomes as a Model with Remarkable Selectivity Against PANC1 and MCF7 Cell Lines.优化的含芦丁聚乙二醇化纳米脂质体作为对PANC1和MCF7细胞系具有显著选择性的模型
Anticancer Agents Med Chem. 2025;25(12):859-872. doi: 10.2174/0118715206231749241209073759.
7
Drug Repurposing: A Conduit to Unravelling Metabolic Reprogramming for Cancer Treatment.药物再利用:揭示癌症治疗中代谢重编程的途径。
Mini Rev Med Chem. 2025;25(8):601-627. doi: 10.2174/0113895575339660250106093738.
8
Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.用于靶向杀死癌细胞的纳米颗粒和基于细胞的药物递送系统的研究进展。
Oncol Res. 2024 Dec 20;33(1):27-44. doi: 10.32604/or.2024.056955. eCollection 2025.
9
Mass balance, metabolic disposition, and pharmacokinetics of a single IV dose of [14C]CA102N in HT-29 xenograft athymic nude mice.[14C]CA102N单次静脉注射剂量在HT - 29异种移植无胸腺裸鼠体内的质量平衡、代谢分布及药代动力学
Front Pharmacol. 2024 Dec 5;15:1440679. doi: 10.3389/fphar.2024.1440679. eCollection 2024.
10
Application of nanotechnology in the treatment of hepatocellular carcinoma.纳米技术在肝细胞癌治疗中的应用。
Front Pharmacol. 2024 Nov 29;15:1438819. doi: 10.3389/fphar.2024.1438819. eCollection 2024.
Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
聚酰胺-胺(PAMAM)树枝状聚合物介导的药物和 pDNA/siRNA 递送至癌症治疗。
Int J Pharm. 2018 Jul 30;546(1-2):215-225. doi: 10.1016/j.ijpharm.2018.05.045. Epub 2018 May 19.
4
Cooperativity Principles in Self-Assembled Nanomedicine.自组装纳米医学中的协同作用原理。
Chem Rev. 2018 Jun 13;118(11):5359-5391. doi: 10.1021/acs.chemrev.8b00195. Epub 2018 Apr 25.
5
Reversal of Ovarian Cancer Multidrug Resistance by a Combination of LAH4-L1-siMDR1 Nanocomplexes with Chemotherapeutics.LAH4-L1-siMDR1 纳米复合物联合化疗逆转卵巢癌多药耐药。
Mol Pharm. 2018 May 7;15(5):1853-1861. doi: 10.1021/acs.molpharmaceut.8b00031. Epub 2018 Apr 11.
6
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.研究性化疗和新型药代动力学机制治疗乳腺癌脑转移。
Pharmacol Res. 2018 Jun;132:47-68. doi: 10.1016/j.phrs.2018.03.021. Epub 2018 Mar 28.
7
Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.金纳米颗粒稳定了肽 - 药物偶联物,以实现对癌细胞的持续靶向药物递送。
J Nanobiotechnology. 2018 Mar 30;16(1):34. doi: 10.1186/s12951-018-0362-1.
8
Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release.通过 GLUT1 介导的和酶触发的线粒体靶向共轭物克服多药耐药性,具有氧化还原敏感的紫杉醇释放。
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12351-12363. doi: 10.1021/acsami.7b18437. Epub 2018 Apr 3.
9
Oseltamivir phosphate released from injectable Pickering emulsions over an extended term disables human pancreatic cancer cell survival.从可注射皮克林乳液中长期释放的磷酸奥司他韦可抑制人胰腺癌细胞的存活。
Oncotarget. 2018 Jan 29;9(16):12754-12768. doi: 10.18632/oncotarget.24339. eCollection 2018 Feb 27.
10
A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin.一种用于协同共递送阿霉素和姜黄素的一体化多功能纳米平台的模块化共组装方法
Nanomaterials (Basel). 2018 Mar 15;8(3):167. doi: 10.3390/nano8030167.